MAPT and supranuclear palsy, progressive, 1: To directly assess the isoform specificity of GT-38 binding, we performed co-IFC staining of tissue sections from patients with AD, CBD and PSP using the IgG2a version of GT-38 in combination with mouse IgG1 3R- or 4R-tau specific antibodies.